Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
05/2012
05/02/2012CN102050780B Quinoline derivatives, and medicament composition and application thereof
05/02/2012CN102048715B Applications of trans-acomhole in preparing medicine or health care products
05/02/2012CN102008640B Oral preparation capable of tonifying qi and building body and preparation method thereof
05/02/2012CN102000316B Traditional Chinese medicine preparation for treating gastrointestinal spasm
05/02/2012CN101940658B Chinese medicinal composition for treating toothache and preparation method thereof
05/02/2012CN101940627B External-use traditional Chinese medicine powder for clearing heat detoxicating, diminishing inflammation and reliving pain
05/02/2012CN101933973B Medicament composition for preventing and treating liver damage
05/02/2012CN101919986B Traditional Chinese medicine composition for treating non-alcoholic fatty liver disease
05/02/2012CN101905025B Preparation method for protective agent of intestinal mucosal barrier
05/02/2012CN101897839B Comprehensive utilization method of banana stalks
05/02/2012CN101869588B Preparation method and application of effective component of chrysanthemum
05/02/2012CN101843628B Application of xanthone compounds to preparing medicine for treating cholestasis
05/02/2012CN101822779B Antipyretic powder containing honeysuckle and indigowoad leaf and preparation method thereof
05/02/2012CN101804068B Polyethylene glycol-electrolyte oral solution
05/02/2012CN101698079B Quality test method of Wenweishu granules
05/02/2012CN101671669B Hepatocellular carcinoma targeting gene expression element AE and applications thereof
05/02/2012CN101632753B Oral medicinal liquor for tonifying qi and blood, nourishing liver and kidney, activating blood circulation by removing blood stasis and clearing and activating channels and collaterals
05/02/2012CN101632752B Health-care wine and preparation method
05/02/2012CN101574476B Medicinal material composition used for lowering lipid and protecting liver auxiliarily
05/02/2012CN101537020B Synbiotics of bacillus licheniformis and oligosaccharide class prebiotics and composition and formulation thereof
05/02/2012CN101502536B Cedar total flavone as well as preparation method and medical use
05/02/2012CN101496894B Medicament for treating fatty liver and preparation method thereof
05/02/2012CN101428090B Tibet picrorhiza rhizome composition with specific spectrum effect relationship
05/02/2012CN101342343B Medicament composition for treating anemia
05/02/2012CN101273745B Health care tea for moistening intestines
05/02/2012CN101144061B Yeast engineering bacterium for producing human pepsinogen and its preparation method and application
05/02/2012CN101129410B Royal jelly enzymolysis product with moisture-absorbing moisture-keeping function
05/02/2012CN101045156B Special target medicine and its use
05/01/2012US8168637 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of diabetes
05/01/2012US8168392 Tetrahydrofolate synthetase gene
05/01/2012US8168189 Protein A compositions and methods of use
05/01/2012CA2545626C Sialogogue, oral composition and food product containing the same
05/01/2012CA2493789C Anthranyl derivatives having an anti cholecystokinin activity (anti-cck-1), a process for their preparation, and pharmaceutical use thereof
05/01/2012CA2455633C Sustained-release therapeutic bioadhesive systems
05/01/2012CA2439928C Bacterial translocation inhibitor and method of inhibiting bacterial translocation
05/01/2012CA2439604C N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation
05/01/2012CA2429625C Hematopoietic cell e-selectin/l-selectin ligand polypeptides and methods of use thereof
05/01/2012CA2322763C Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial uc panca antigens
04/2012
04/26/2012WO2012054535A2 Compounds, compositions and methods useful for cholesterol mobilisation
04/26/2012WO2012054530A2 Chemosensory receptor ligand-based therapies
04/26/2012WO2012054528A2 Chemosensory receptor ligand-based therapies
04/26/2012WO2012054527A2 Chemosensory receptor ligand-based therapies
04/26/2012WO2012054376A2 Metal ion nanoclusters
04/26/2012WO2012053758A2 Pharmaceutical composition for treating or preventing alcoholic liver diseases, containing cilostazol as active ingredient
04/26/2012WO2012052918A1 Use of mexiprostil in the treatment of inflammatory bowel disease and/or of irritable bowel syndrome
04/26/2012WO2012052463A1 Cysteine and food intake
04/26/2012WO2012052060A1 Method to increase the growth velocity of human infants
04/26/2012WO2012052059A1 Method to increase the absorption of unsaturated fatty acids by human infants
04/26/2012WO2012029015A3 Anticaries dentifrice composition that includes anticaries propolis as an active principle
04/26/2012WO2012007839A3 Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract
04/26/2012WO2011058474A8 N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors
04/26/2012US20120101161 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders
04/26/2012US20120101136 5-membered heteroaryl derivatives used as sphingosine 1- phosphate receptor agonists
04/26/2012US20120101124 1,2,4-oxadiazol derivatives, their pharmaceutical compositions and their use as sphingosine 1-phosphate 1 receptor agonists
04/26/2012US20120101123 Compounds
04/26/2012US20120101120 Pure isomers of tritoqualine
04/26/2012US20120101112 SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
04/26/2012US20120101107 Piperazine dithioctate and pharmaceutical composition comprising the same
04/26/2012US20120101105 Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
04/26/2012US20120101089 Anti-Emetic Substance
04/26/2012US20120101086 Thiadiazole derivatives and their use for the treatment of disorders mediated by s1p1 receptors
04/26/2012US20120101082 Vasopressin v1a antagonists
04/26/2012US20120101058 Pharmaceutical Composition For Prevention Or Treatment Of Lifestyle-Related Disease, And Food Useful For Prevention Or Treatment Of Lifestyle-Related Disease
04/26/2012US20120101052 15-thia steroid compounds and compositions
04/26/2012US20120101042 Agents and Methods for Tissue Repair and Regeneration
04/26/2012US20120101039 Calcium-sensing receptor-active compounds
04/26/2012US20120101032 Novel macrocyclic inhibitors of hepatitis c virus replication
04/26/2012US20120101028 Anti-inflammatory compounds and uses thereof
04/26/2012US20120101026 Compounds For Enzyme Inhibition
04/26/2012US20120101025 Compounds For Enzyme Inhibition
04/26/2012US20120100235 Papaya puree and uses thereof
04/26/2012US20120100213 Pharmaceutical formulations of a substituted diaminopurine
04/26/2012US20120100194 Chewing gum composition, chewing gum product, and method for manufacturing same
04/26/2012US20120100192 Local therapeutic release device
04/26/2012US20120100191 Methods and devices for delivery of pharmaceutical agents within orifices of the body
04/26/2012US20120100166 Ang-2 Binding Complexes and Uses Thereof
04/26/2012US20120100161 Amatoxin-Armed Therapeutic Cell Surface Binding Components Designed for Tumour Therapy
04/26/2012US20120100147 Novel antibodies and their uses in therapeutic and diagnostic methods
04/26/2012US20120100143 Immunogenic proteins from genome-derived outer membrane of leptospira and compositions and methods based thereon
04/26/2012US20120100139 CD86 Antagonist Multi-Target Binding Proteins
04/26/2012US20120100126 Method to Increase the Growth Velocity of Human Infants
04/26/2012US20120100115 Regionalised endoderm cells and uses thereof
04/26/2012US20120100110 Physiological methods for isolation of high purity cell populations
04/26/2012US20120100103 In situ forming hydrogel and biomedical use thereof
04/26/2012US20120100074 Humanized antibodies against light and uses thereof
04/26/2012DE102010049595A1 Chinazolinderivate Quinazoline derivatives
04/26/2012CA2815145A1 Metal ion nanoclusters
04/26/2012CA2815109A1 Cysteine and food intake
04/26/2012CA2812891A1 Use of mexiprostil in the treatment of inflammatory bowel disease and/or of irritable bowel syndrome
04/26/2012CA2812857A1 Method to increase the growth velocity of human infants
04/26/2012CA2812852A1 Method to increase the absorption of unsaturated fatty acids by human infants
04/25/2012EP2444401A1 Novel imidazopyridine compound
04/25/2012EP2444097A1 Nfat signal inhibitor and calcineurin inhibitor
04/25/2012EP2444094A1 Mangiferin-berberine salt, manufacturing method and use thereof
04/25/2012EP2444083A1 Cysteine and food intake
04/25/2012EP2444082A2 Hydroxymethylbutyrate compositions and uses thereof
04/25/2012EP2443144A1 Sap variants and their use
04/25/2012EP2442803A1 Modulation of systemic exposure to rifaximin
04/25/2012EP2181122B1 Monomeric vhh domain derived from anti-vp6 camelid antibodies, dimeric domain, immunisation method, rotavirus detection method, composition, prevention and treatment methods for rotavirus infections
04/25/2012EP2020234B1 Synergic combination of pinaverium bromide and dimethicone or simethicone
1 ... 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 ... 1258